4.4 Article

Trends and Socioeconomic Health Outcomes of Cannabis Use Among Patients With Gastroparesis A United States Nationwide Inpatient Sample Analysis

Journal

JOURNAL OF CLINICAL GASTROENTEROLOGY
Volume 56, Issue 4, Pages 324-330

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCG.0000000000001526

Keywords

gastroparesis; cannabis use; health care disparities; health outcomes

Funding

  1. NIH [T32 DK007533-35]

Ask authors/readers for more resources

The study found that patients with gastroparesis and cannabis use disorder were younger, had lower socioeconomic status, and were disproportionately affected by psychiatric diagnoses. However, these patients had better hospitalization outcomes, including decreased length of stay and improved in-hospital mortality.
Background: Although cannabis may worsen nausea and vomiting for patients with gastroparesis, it may also be an effective treatment for gastroparesis-related abdominal pain. Given conflicting data and a lack of current epidemiological evidence, we aimed to investigate the association of cannabis use on relevant clinical outcomes among hospitalized patients with gastroparesis. Materials and Methods: Patients with a diagnosis of gastroparesis were reviewed from the National Inpatient Sample (NIS) database between 2008 and 2014. Gastroparesis was identified by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes with patients classified based on a diagnosis of cannabis use disorder. Demographics, comorbidities, socioeconomic status, and outcomes were compared between cohorts using chi(2) and analysis of variance. Logistic regression was then performed and annual trends also evaluated. Results: A total of 1,473,363 patients with gastroparesis were analyzed [n=33,085 (2.25%) of patients with concomitant cannabis use disorder]. Patients with gastroparesis and cannabis use disorder were more likely to be younger and male gender compared with nonusers (36.7 +/- 18.8 vs. 51.9 +/- 16.8; PP<0.001, respectively). Race/ethnicity was different between groups (P<0.001). Cannabis users had a lower median household income and were more likely to have Medicaid payor status (all P<0.001). Controlling for confounders, length of stay, and mortality were significantly decreased for patients with gastroparesis and cannabis use (all P<0.001). Conclusion: While patients with gastroparesis and cannabis use disorder were younger, with a lower socioeconomic status, and disproportionately affected by psychiatric diagnoses, these patients had better hospitalization outcomes, including decreased length of stay and improved in-hospital mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available